Major components of metabolic syndrome and adiponectin levels: A cross-sectional study

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Von Frankenberg, Anize D ^a,b   Do Nascimento, Filipe V ^a   Gatelli, Lucas Eduardo ^a   Nedel, Bárbara L ^a   Garcia, Sheila P ^a   De Oliveira, Carolina S ^c   Saddi Rosa, Pedro ^c   Reis, André F ^c   Canani, Luis H ^a,b   Gerchman, Fernando ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiponectin; Metabolic syndrome; Obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELEVATED BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOLECULAR WEIGHT; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84895921903     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-26     Document Type: Article

References (29)

1. Obesity: preventing and managing the global epidemic of obesity. WHO, Book Obesity: Preventing and Managing the Global Epidemic of Obesity Geneva, Switzerland: World Health Organization Reprinted 2004
2. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Ford ES, Diabetes Care 2005 28 1769 1778 10.2337/diacare.28.7.1769 15983333
3. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR, Circulation 2004 110 1245 1250 10.1161/01.CIR.0000140677.20606.0E 15326067
4. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
5. Prevalence and trends of metabolic syndrome in the adult US population, 1999-2010. Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S, J Am Coll Cardiol 2013 62 697 703 10.1016/j.jacc.2013.05.064 23810877
6. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. Vega GL, Grundy SM, J Obes 2013 2013 409679 23533722
7. Metabolic actions of adipocyte hormones: focus on adiponectin. Ahima RS, Obesity (Silver Spring) 2006 14 Suppl 1 9S 15S 16642957
8. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT, Diabetes 2006 55 249 259 10.2337/diabetes.55.01.06.db05-1105 16380500
9. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y, Biochem Biophys Res Commun 1999 257 79 83 10.1006/bbrc.1999.0255 10092513
10. Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. Oliveira CS, Saddi-Rosa P, Crispim F, Canani LH, Gerchman F, Giuffrida FM, Vieira JG, Velho G, Reis AF, J Diabetes Complications 2012 26 94 98 10.1016/j.jdiacomp.2012.02.008 22459242
11. Global database on body mass index. BMI classification. [ http://www.who.int/bmi/index.jsp?introPage=intro-3.html ]
12. Executive summary: Standards of medical care in diabetes - 2010. Diabetes Care 2010 33 Suppl 1 4 S10 20042774
13. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825
14. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Matsuda M, DeFronzo RA, Diabetes Care 1999 22 1462 1470 10.2337/diacare.22.9.1462 10480510
15. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, et al. JAMA 2005 294 1799 1809 16219884
16. Hemostatic factors and the metabolic syndrome. Kostapanos M, Florentin M, Elisaf MS, Mikhailidis DP, Curr Vasc Pharmacol 2013 11 880 905
17. Causal relationship between adiponectin and metabolic traits: a mendelian randomization study in a multiethnic population. Mente A, Meyre D, Lanktree MB, Heydarpour M, Davis AD, Miller R, Gerstein H, Hegele RA, Yusuf S, Anand SS, PLoS One 2013 8 66808 10.1371/journal.pone.0066808 23826141
18. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE, Nat Med 2001 7 947 953 10.1038/90992 11479628
19. Enhanced metabolic flexibility associated with elevated adiponectin levels. Asterholm IW, Scherer PE, Am J Pathol 2010 176 1364 1376 10.2353/ajpath.2010.090647 20093494
20. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE, J Clin Invest 2007 117 2621 2637 10.1172/JCI31021 17717599
21. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J, Metabolism 2011 60 313 326 10.1016/j.metabol.2010.09.003 21040935
22. Enhanced fatty acid flux triggered by adiponectin overexpression. Shetty S, Ramos-Roman MA, Cho YR, Brown J, Plutzky J, Muise ES, Horton JD, Scherer PE, Parks EJ, Endocrinology 2012 153 113 122 10.1210/en.2011-1339 22045665
23. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O'Brien PE, Dixon JB, Cameron-Smith D, Kemp BE, Steinberg GR, J Clin Endocrinol Metab 2005 90 3665 3672 10.1210/jc.2004-1980 15769985
24. Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients. Debard C, Laville M, Berbe V, Loizon E, Guillet C, Morio-Liondore B, Boirie Y, Vidal H, Diabetologia 2004 47 917 925 10.1007/s00125-004-1394-7 15127202
25. Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Fuentes E, Fuentes F, Vilahur G, Badimon L, Palomo I, Mediators Inflamm 2013 2013 136584 23843680
26. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men. Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF, J Clin Endocrinol Metab 2009 94 989 997 10.1210/jc.2008-1457 19116237
27. Adiponectin is an important determinant of apoA-I catabolism. Verges B, Petit JM, Duvillard L, Dautin G, Florentin E, Galland F, Gambert P, Arterioscler Thromb Vasc Biol 2006 26 1364 1369 10.1161/01.ATV.0000219611.50066.bd 16574896
28. Variability in postheparin hepatic lipase activity is associated with plasma adiponectin levels in African Americans. Clarenbach JJ, Vega GL, Adams-Huet B, Considine RV, Ricks M, Sumner AE, J Investig Med 2007 55 187 194 10.2310/6650.2007.07001 17651673
29. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA, Diabetes Care 2005 28 2181 2186 10.2337/diacare.28.9.2181 16123487